drugset

drugset / Trial / NCT00624559

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

NCT00624559 ↗

Phase 4 Completed 12 enrolled University of Delaware Christiana Care Health Services · collab

RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to determine if the drug Celebrex changes the way the kidney gets rid of salt and maintains blood pressure.

Timeline

Start: 2008-02
Primary completion: 2009-01
Completion: 2009-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Celecoxib	Other / unclassified	100 mg	—

Indications